[Department of Error] Department of Error
Devereaux PJ, Duceppe E, Guyatt G, et al. Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial. Lancet 2018; 391: 2325–34—In the final sentence of the Interpretation in the Summary, the dose of dabigatran was recorded incorrectly. The sentence should read “Patients with MINS have a poor prognosis; dabigatran 110 mg twice daily has the potential to help many of the 8 million adults globally who have MINS to reduce their risk of a major vascular complication.” This correction has been made to the online version as of July 5, 2018.